Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT04993508Not ApplicableNot Yet Recruiting

Randomized Prospective Multi Center Cohort Study for Primary Diagnosis of Clinically Significant Prostate Cancer With Combination of PSA/DRE and Multi Parametric Magnetic Resonance Imaging

Role: collaborator

NCT07072143Recruiting

An International Study on Pediatric Patients With Rare Tumors.

Role: collaborator

NCT03356392Recruiting

German Stroke Registry - Endovascular Treatment

Role: collaborator

NCT03682146Not ApplicableCompleted

Laparoscopic vs Robotic-Assisted Radical Prostatectomy

Role: collaborator

All 4 trials loaded